|
155
|
Safety Signal of ChAdOx1-S/nCoV-19 vaccine and the Risk of Chronic inflammatory demyelinating polyneuropathy (CIDP)
|
|
Signal
|
|
|
154
|
Safety Signal of Progesterone and the Risk of Meningioma
|
|
Signal
|
|
|
153
|
Safety Signal of Atorvastatin and the Risk of Erectile dysfunction
|
|
Signal
|
|
|
152
|
Safety Signal of Levothyroxine and Risk of Vertigo
|
|
Signal
|
|
|
151
|
Safety Signal of Etoposide and Risk of Electrolyte imbalance
|
|
Signal
|
|
|
150
|
Safety Signal of Amlodipine and Risk of Hyperkalaemia
|
|
Signal
|
|
|
149
|
Safety Signal of Prednisolone and the Risk of Hypomagnesaemia
|
|
Signal
|
|
|
148
|
Safety Signal of Cytarabine and the Risk of Tumour lysis syndrome
|
|
Signal
|
|
|
147
|
New recommendations for reducing the risk of serious side effects associated with Janus kinase inhibitors in chronic inflammatory diseases.
|
|
Signal
|
|
|
146
|
Safety Signal of Prednisone and the Risk of Osteonecrosis
|
|
Signal
|
|
